Rituximab-Based Treatment, HCV Replication, and Hepatic Flares
Rituximab, a chimeric mouse-human monoclonal antibody directed to the CD20 antigen expressed on pre-B lymphocytes and mature lymphocytes, causes a profound B-cell depletion.Due to its peculiar characteristics, this drug has been bearing cover used to treat oncohaematological diseases, B cell-related autoimmune diseases, rheumatoid arthritis, and, m